Should You Buy Netflix Stock Before July 16? Here's My Honest Answer

Netflix’s shares are down 42% from their July 2025 peak, creating an earnings-day “buy or pain” setup ahead of its Q2 report on July 16. In Q1, revenue rose 16% to $12.25B and EPS jumped 86% to $1.23 (supported by a $2.8B Warner Bros. termination fee), while full-year revenue growth guidance remains ~13% (midpoint) and the company targets doubling ad revenue from $1.5B to $3B. The article argues the key swing factor is Netflix’s low valuation (about 24x earnings), implying limited fundamental deterioration despite the acquisition-related headlines.

Analysis

The drawdown looks more like multiple compression from narrative noise than a fundamental break. For NFLX, the key mechanism is that management has chosen capital discipline over empire-building, which should preserve ROIC while competitors that chase assets face integration and leverage risk. If the market stops confusing "not buying" with "no strategy," the stock can re-rate quickly because the underlying business still has operating leverage from ads and pricing, not from M&A.

The immediate catalyst is the earnings print: the market will care less about headline growth than whether ad monetization is tracking toward the doubled run-rate and whether content spend remains front-loaded without killing margins. Over the next 1-3 months, a clean guide could trigger multiple expansion, while any hint that ad ramp is slipping or content costs are stickier than expected would likely extend the de-rating. The second-order winner from a consolidated streaming landscape is NFLX itself, because it can keep self-funding growth while rivals like ROKU and WBD remain more exposed to cyclical ad and financing pressure.

Contrarian view: the consensus may be underestimating how much of the current weakness is already in the price, but also overestimating how cheap 24x earnings is if the ad business stalls. The thesis is falsified if Q2 commentary implies flat-to-down margin trajectory, weaker-than-expected engagement, or no visible path for advertising to accelerate into 2H. Structurally, the next 6-18 months matter more than one quarter: if NFLX keeps compounding revenue mid-teens with stable FCF conversion, this becomes a quality-growth re-rating rather than a value trap.

Key Decisions for Investors

• Long NFLX into earnings via stock or a modest call spread; best entry is on any pre-print weakness. Risk/reward is attractive if ad revenue commentary confirms the 2H ramp, but cut if management softens margin guidance.
• Pair trade: long NFLX / short ROKU for 1-3 months. Thesis: NFLX benefits from clean organic execution while ROKU remains a lower-quality ad proxy with more downside if the macro ad cycle disappoints.
• Avoid chasing WBD or other 'strategic asset' names on M&A chatter; the market is likely overpaying for optionality. If you want exposure, use NFLX as the cleaner compounding asset rather than deal-risk beta.
• Set a post-earnings alert: if NFLX does not confirm ad revenue acceleration and stable content-spend phasing, take profits or reduce. That is the key falsifier for the rerating thesis.